Results 241 to 250 of about 75,890 (310)

Nuclear Mechanotransduction Across the Metastatic Cascade: Decoding Spatiotemporal Heterogeneity in Cancer Dissemination

open access: yesAdvanced Science, Volume 13, Issue 25, 4 May 2026.
Tumor metastasis results from complex interactions between cancer cells and mechanical microenvironments. We propose a “nucleus‐centered, cross‐stage mechanical signal decoding” model, highlighting how nuclear mechanosensors interpret forces at different stages.
Linqi Song   +4 more
wiley   +1 more source

Immunotherapy and Breast Reconstruction: Opportunities, Challenges, and Future Directions

open access: yesCancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Immunotherapy is transforming breast cancer management, but it also presents new challenges for surgical and reconstructive practice. This review summarizes current evidence on immune checkpoint inhibitors, perioperative safety, and immune‐related adverse events, highlighting their impact on surgical timing, postoperative recovery, and ...
Shuang Li   +6 more
wiley   +1 more source

Multi‐Transcriptomic Analysis Reveals That EREG‐Driven TME Crosstalk Defines Anti‐EGFR Response in Colorectal Cancer

open access: yesCancer Medicine, Volume 15, Issue 5, May 2026.
A multi‐transcriptomic analysis reveals the “EREG/EGFR/CSF axis” as a key intercellular network in the tumor microenvironment that dictates anti‐EGFR sensitivity in colorectal cancer. ABSTRACT Sidedness influences colorectal cancer (CRC) prognosis and treatment response, yet the mechanism dictating differential EGFR inhibitor (EGFRI) sensitivity is ...
Atsuki Taniguchi   +9 more
wiley   +1 more source

Modern Clinical Trials: Seamless Designs and Master Protocols

open access: yesCancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Background Drug development is often inefficient, costly and lengthy, yet it is essential for evaluating the safety and efficacy of new interventions. Compared with other disease areas, this is particularly true for Phase II/III cancer clinical trials where many drug candidates fail to advance and reduced regulatory approvals are being seen ...
Abigail Burdon   +5 more
wiley   +1 more source

Prognostic model for resected borderline and locally advanced pancreatic cancer after neoadjuvant chemotherapy. [PDF]

open access: yesInt J Surg
Son J   +10 more
europepmc   +1 more source

Predicting Prognosis for Gastric Cancer Patients Receiving Neoadjuvant Treatment With Body Composition‐Based Deep Learning

open access: yesCancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Background This study sought to develop an innovative body composition (BC)‐based deep learning (DL) model to precisely evaluate survival in gastric cancer (GC) patients undergoing neoadjuvant treatment (NT). Materials and Methods This retrospective study included GC patients undergoing NT from two centers.
Yingjing Zhang   +6 more
wiley   +1 more source

Nationwide implementation of the international multidisciplinary best-practice for locally advanced pancreatic cancer (PREOPANC-4): study protocol. [PDF]

open access: yesBMC Cancer
Stoop TF   +57 more
europepmc   +1 more source

Contrasting Ocular Manifestations of Xeroderma Pigmentosum in Siblings

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Xeroderma Pigmentosum (XP) can present with markedly different ocular severities even among siblings sharing the same genetic background. Early detection and preventive care are crucial to reduce the risk of vision‐ and life‐threatening malignancies.
Mohammad Taher Rajabi   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy